Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Morphic Holding Inc (NQ: MORF )

55.99 +0.06 (+0.11%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,715,101
Open 55.95
Bid (Size) 55.99 (8)
Ask (Size) 56.02 (1)
Prev. Close 55.93
Today's Range 55.91 - 56.19
52wk Range 19.34 - 62.08
Shares Outstanding 36,415,045
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Americans Are Flying; Airline Stocks Are Not
How the airline industry's focus on capacity and being able to supply more flights means fares are low, even in the face of record demand. 
Via The Motley Fool
3 Stocks for Patient Investors Looking to Build Generational Wealth
Investing in generational wealth stocks means holding them for years, preferably decades, to allow them to deliver supercharged returns. 
Via InvestorPlace

Performance

YTD
+93.54%
+93.54%
1 Month
+114.36%
+114.36%
3 Month
+89.73%
+89.73%
6 Month
+101.04%
+101.04%
1 Year
-5.65%
-5.65%

More News

Read More
Russell 2000 Index Notches Strongest Week Of Year, Hits 31-Month Highs: Outlook Is 'Clouded By Fed's Concerns Over Labor Market,' Analyst Warns
Via Benzinga
Topics Economy
Exposures Interest Rates
Stock Market Shifts Toward Small Caps After Tame CPI; JPMorgan, Taiwan Semi, Tesla In Focus: Weekly Review
Via Investor's Business Daily
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPR, MORF on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MORF, INFN, AMBC, BEST on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
MORPHIC HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Morphic Holding, Inc. - MORF
From Kahn Swick & Foti, LLC
Via Business Wire
Eli Lilly's $3.2B Morphic Deal Is 'Crucial,' Has 'Strategic Merit' Despite Investor Attention On Obesity: Analyst
Via Benzinga
Eli Lilly Finalizes Acquisition Agreement to Acquire Morphic for $3.2 Billion – InsideArbitrage
Via AB Newswire
Hot Stocks: 3 Sleeping Giants About to Dominate Their Sectors
Via InvestorPlace
S&P 500 Closes At Record High Ahead Of Inflation Data: Fear & Greed Index Remains In 'Neutral' Zone
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Patients Lost More Weight On Eli Lilly's Mounjaro Than Novo Nordisk's Ozempic
Via Investor's Business Daily
Gold Falls Over 1%; HilleVax Shares Plunge
Via Benzinga
Stocks Hold Steady, Small Caps Rise, French Equities Slip After Surprise Win By Left-Wing Bloc: What's Driving Markets Monday?
Via Benzinga
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Dow Turns Lower; Myomo Shares Jump
Via Benzinga
Topics Stocks
Exposures US Equities
Microsoft Layoffs 2024: What to Know as MSFT Enacts More Job Cuts
Via InvestorPlace
Topics Workforce
Exposures Layoff
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, MORF, AGR on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
NVDA Stock Warning: EU Watchdogs Are Sizing Up Nvidia
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Is Morphic (MORF) Stock Up 75% Today?
Via InvestorPlace
Corning Increases Sales Forecast, Joins Morphic Holding, Lucid Group And Other Big Stocks Moving Higher On Monday
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Morphic Holding, Inc. (Nasdaq - MORF), Desktop Metal, Inc. (NYSE - DM), Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR)
From Brodsky & Smith LLC
Via GlobeNewswire
Dow Jumps Over 200 Points; Greenbrier Shares Fall After Q3 Results
Via Benzinga
Topics Stocks
Exposures US Equities
Eli Lilly's First Biotech Deal Of 2024, Buys Chronic Disease Player Morphic For $3.2B
Via Benzinga
Eli Lilly Snaps Up Morphic At 79% Premium
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.